FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2513929170> ?p ?o ?g. }

• W2513929170 endingPage "948" @default.
• W2513929170 startingPage "940" @default.
• W2513929170 abstract "Only a small proportion of patients respond to anti-VEGF therapy, pressing the need for a reliable biomarker that can identify patients who will benefit. We studied the biological activity of anti-VEGF antibodies in patients' blood during anti-VEGF therapy by using the Ba/F3-VEGFR2 cell line, which is dependent on VEGF for its growth.Serum samples from 22 patients with cancer before and during treatment with bevacizumab were tested for their effect on proliferation of Ba/F3-VEGFR2 cells. Vascular endothelial growth factor as well as bevacizumab concentrations in serum samples from these patients were determined by enzyme linked immunosorbent assay (ELISA).The hVEGF-driven cell proliferation was effectively blocked by bevacizumab (IC50 3.7 μg ml-1; 95% CI 1.7-8.3 μg ml-1). Cell proliferation was significantly reduced when patients' serum during treatment with bevacizumab was added (22-103% inhibition compared with pre-treatment). Although bevacizumab levels were not related, on-treatment serum VEGF levels were correlated with Ba/F3-VEGFR2 cell proliferation.We found that the neutralising effect of anti-VEGF antibody therapy on the biological activity of circulating VEGF can be accurately determined with a Ba/F3-VEGFR2 bioassay. The value of this bioassay to predict clinical benefit of anti-VEGF antibody therapy needs further clinical evaluation in a larger randomised cohort." @default.
• W2513929170 created "2016-09-16" @default.
• W2513929170 creator A5003107448 @default.
• W2513929170 creator A5011171028 @default.
• W2513929170 creator A5011288026 @default.
• W2513929170 creator A5013858600 @default.
• W2513929170 creator A5022897881 @default.
• W2513929170 creator A5025933404 @default.
• W2513929170 creator A5034726436 @default.
• W2513929170 creator A5053105927 @default.
• W2513929170 creator A5057751944 @default.
• W2513929170 creator A5088663155 @default.
• W2513929170 date "2016-08-30" @default.
• W2513929170 modified "2023-10-16" @default.
• W2513929170 title "A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer" @default.
• W2513929170 cites W142627405 @default.
• W2513929170 cites W1554964268 @default.
• W2513929170 cites W1595931622 @default.
• W2513929170 cites W1968504912 @default.
• W2513929170 cites W1970421475 @default.
• W2513929170 cites W1986552377 @default.
• W2513929170 cites W1991994014 @default.
• W2513929170 cites W1995031555 @default.
• W2513929170 cites W1997481880 @default.
• W2513929170 cites W2009786335 @default.
• W2513929170 cites W2011849510 @default.
• W2513929170 cites W2016946888 @default.
• W2513929170 cites W2019474002 @default.
• W2513929170 cites W2026183296 @default.
• W2513929170 cites W2072143531 @default.
• W2513929170 cites W2076828545 @default.
• W2513929170 cites W2088563616 @default.
• W2513929170 cites W2095374934 @default.
• W2513929170 cites W2095439192 @default.
• W2513929170 cites W2096396175 @default.
• W2513929170 cites W2108950512 @default.
• W2513929170 cites W2109154357 @default.
• W2513929170 cites W2109491042 @default.
• W2513929170 cites W2114639921 @default.
• W2513929170 cites W2116464761 @default.
• W2513929170 cites W2116991471 @default.
• W2513929170 cites W2120863072 @default.
• W2513929170 cites W2122152991 @default.
• W2513929170 cites W2122298066 @default.
• W2513929170 cites W2134025982 @default.
• W2513929170 cites W2135747342 @default.
• W2513929170 cites W2142167347 @default.
• W2513929170 cites W2142765731 @default.
• W2513929170 cites W2143743735 @default.
• W2513929170 cites W2144437076 @default.
• W2513929170 cites W2144660856 @default.
• W2513929170 cites W2145187086 @default.
• W2513929170 cites W2145835533 @default.
• W2513929170 cites W2146026405 @default.
• W2513929170 cites W2147219678 @default.
• W2513929170 cites W2148532787 @default.
• W2513929170 cites W2155591311 @default.
• W2513929170 cites W2156575195 @default.
• W2513929170 cites W2157769714 @default.
• W2513929170 cites W2158134782 @default.
• W2513929170 cites W2161688555 @default.
• W2513929170 cites W2162944147 @default.
• W2513929170 cites W2209622402 @default.
• W2513929170 cites W2255518001 @default.
• W2513929170 cites W2293809486 @default.
• W2513929170 cites W2337751219 @default.
• W2513929170 cites W2342654843 @default.
• W2513929170 cites W2395418662 @default.
• W2513929170 cites W3120856923 @default.
• W2513929170 cites W69759415 @default.
• W2513929170 doi "https://doi.org/10.1038/bjc.2016.275" @default.
• W2513929170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5061906" @default.
• W2513929170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27575850" @default.
• W2513929170 hasPublicationYear "2016" @default.
• W2513929170 type Work @default.
• W2513929170 sameAs 2513929170 @default.
• W2513929170 citedByCount "4" @default.
• W2513929170 countsByYear W25139291702020 @default.
• W2513929170 countsByYear W25139291702021 @default.
• W2513929170 countsByYear W25139291702022 @default.
• W2513929170 crossrefType "journal-article" @default.
• W2513929170 hasAuthorship W2513929170A5003107448 @default.
• W2513929170 hasAuthorship W2513929170A5011171028 @default.
• W2513929170 hasAuthorship W2513929170A5011288026 @default.
• W2513929170 hasAuthorship W2513929170A5013858600 @default.
• W2513929170 hasAuthorship W2513929170A5022897881 @default.
• W2513929170 hasAuthorship W2513929170A5025933404 @default.
• W2513929170 hasAuthorship W2513929170A5034726436 @default.
• W2513929170 hasAuthorship W2513929170A5053105927 @default.
• W2513929170 hasAuthorship W2513929170A5057751944 @default.
• W2513929170 hasAuthorship W2513929170A5088663155 @default.
• W2513929170 hasBestOaLocation W25139291701 @default.
• W2513929170 hasConcept C104488531 @default.
• W2513929170 hasConcept C121608353 @default.
• W2513929170 hasConcept C126322002 @default.
• W2513929170 hasConcept C143998085 @default.
• W2513929170 hasConcept C146285616 @default.
• W2513929170 hasConcept C159654299 @default.

• next